𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Clinical evaluation of urolithiasis in Crohn's disease

✍ Scribed by Genichi Ishii; Kouichi Nakajima; Norie Tanaka; Hiroshi Hara; Moriaki Kato; Nobuhisa Ishii

Book ID
108977955
Publisher
John Wiley and Sons
Year
2009
Tongue
English
Weight
133 KB
Volume
16
Category
Article
ISSN
0919-8172

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical features of Crohn’s disease in
Clinical features of Crohn’s disease in Korea
✍ Yoon, Chong Mann ;Kim, Suk Bin ;Park, Il Jong ;Bom, Hee Seung ;Rhew, Jong Sun ;C πŸ“‚ Article πŸ“… 1988 πŸ› Springer-Verlag 🌐 English βš– 441 KB
Circulating midkine in Crohn's disease:
Circulating midkine in Crohn's disease: Clinical implications
✍ Malgorzata Krzystek-Korpacka; Katarzyna Neubauer; Malgorzata Matusiewicz πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 124 KB

Background: A noninvasive marker facilitating differential diagnosis in Crohn's disease (CD) is sought after. Midkine is a heparin-binding growth factor of angiogenic and chemotactic properties, positively evaluated as a tumor marker, and a possible association with CD has not yet been investigated.

Clinical course of late-onset Crohn's di
Clinical course of late-onset Crohn's disease
✍ Erika Angelucci; Andrea Cocco; Giovanni Latella; Renzo Caprilli πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 61 KB πŸ‘ 1 views
Endpoints for clinical trials evaluating
Endpoints for clinical trials evaluating disease modification and structural damage in adults with Crohn's disease
✍ Geert R. D'Haens; Richard Fedorak; Marc LΓ©mann; Brian G. Feagan; Michael A. Kamm πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 91 KB πŸ‘ 1 views

The management of Crohn's disease is rapidly changing. The advent of potent immunomodulatory and biologic therapies has led to more demanding endpoints for clinical trials than only clinical response and remission. Complete withdrawal of corticosteroids, healing of endoscopically visible lesions, an